داروشناسی روان‌پزشکی کودکان برای مراقبت‌های اولیه

Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. It includes digital tools offering instant access to additional information on psychotropic medications. TOPICS INCLUDE Conceptual framework for prescribing psychotropics Newly approved medications, changes in regulations and guidelines, and updates in the professional literature are included in this new edition Medications for specific diagnoses—ADHD, anxiety, and depression Food and Drug Administration approved antipsychotics and mood stabilizers and all other medications What to do when treatment is unsuccessful Introduction 18 Target Audience 18 Why Now? 18 What Does This Book Contribute? 19 References 20 Part 1: Before Prescribing 22 Chapter 1: Getting Started 24 Guiding Psychopharmacology Principles 24 Additional Guiding Principles 25 Organization and Overview 26 Selected Changes and Updates in Third Edition 27 Chapter 2: Conceptual Framework for Prescribing Psychotropic Medications 28 Rationale for the Conceptual Framework 28 Group 1 Medications for Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression 31 Group 2 Medications 36 Group 3 Medications 38 References 39 Chapter 3: Making a Diagnosis 40 Overview 40 Diagnosis of Common Disorders: ADHD, Anxiety Disorders, and Depression 40 Diagnosis of Common Comorbidities of ADHD, Anxiety Disorders, and Depression 53 Recognizing Other Psychiatric Disorders 60 Determine if Medication Is Indicated 61 Recognize Need for Referral 62 References 64 Chapter 4: Laying the Groundwork 66 Formulation 66 Feedback 67 Nonmedication Interventions 69 Informed Consent 72 Specific Consent Issues 73 Off-label Prescribing 78 US Food and Drug Administration Boxed Warnings 79 Triage for Psychiatric and Social Emergencies 81 Important Considerations for Safe and Effective Prescribing 81 References 82 Part 2: Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression 86 Chapter 5: Group 1 Medications for Attention-Deficit/Hyperactivity Disorder 88 General Guidance 88 Methylphenidate 91 Amphetamine 99 Guanfacine 107 Clonidine 114 Atomoxetine 121 Viloxazine 127 Summary 131 References 131 Chapter 6: Group 1 Medications for Anxiety and Depression 134 General Guidance 134 Group 1 Selective Serotonin Reuptake Inhibitors 138 Group 1 Serotonin and Norepinephrine Reuptake Inhibitor: Duloxetine 146 Summary 150 References 151 Part 3: Group 2 and Group 3 Medications 152 Chapter 7: Group 2 Medications: FDA-Approved Antipsychotics and Mood Stabilizers 154 Rationale 154 Antipsychotics 155 The Mood Stabilizer Lithium 166 Summary 173 References 174 Chapter 8: Group 3 Medications: Others Commonly Prescribed 176 Other Antidepressants 176 Other Antipsychotics 182 Other Mood Stabilizers 183 Anxiolytics 183 Sleep Aids 184 Future Considerations 186 References 186 Part 4: After Prescribing: Midcourse Corrections 188 Chapter 9: Fine Tuning Treatment 190 Reevaluate Therapies 190 Reevaluate Medication 191 Discontinuing Group 1 Medications 192 Switching Group 1 Medications 193 When to Consider Group 2 Antipsychotics or Lithium 194 When to Consider Group 3 Medications Without FDA Approval for Use in Youth 195 When to Consider Drug Levels or Genetic Testing 195 Can Genotyping Improve Medication Response? 197 When to Consider Consultation or a Second Opinion 197 References 197 Chapter 10: Managing Treatment Impasses 200 Reassess Diagnoses 200 Complex Psychosocial Presentations 203 Expert Consultation or Referral 203 Reference 204 Appendixes 206 A. Assessment and Symptom Monitoring Tools 208 B. Resources for Clinicians 212 C. Training Resources for Clinicians 216 D. Quality Ratings for Psychotherapies and Efficacy Data for Medications 218 E. Resources for Caregivers 224 F. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnoses 226 Index 234 Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. -- Provided by publisher